InflaRx (IFRX) Current Leases (2019 - 2026)
InflaRx's (IFRX) quarterly Current Leases came in at $316958.6 in Q2 2026, down 29.15% year-over-year from $447389.0 in Q2 2025, and up 7.74% quarter-over-quarter from $294197.8 in Q1 2026.
Analysis
InflaRx (IFRX) Current Leases (2019 - 2026) Analysis & Trends
InflaRx has disclosed Current Leases across 8 years of filings, most recently posting $316958.6 for Q2 2026.
- In Q2 2026, Current Leases fell 29.15% year-over-year to $316958.6; the TTM figure through Jun 2026 stood at $316958.6 (down 29.15% YoY), while the FY2025 annual figure was $290297.1, down 33.09% from the prior year.
- Current Leases came in at $316958.6 for Q2 2026 at InflaRx, up from $294197.8 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $447389.0 in Q2 2025 to a low of $294197.8 in Q1 2026.
- Average Current Leases over 5 years is $385884.3, with a median of $393617.3 recorded in 2023.
- Year-over-year, Current Leases climbed 13.65% in 2024 and slumped 31.31% in 2026.
- Over 5 years, Current Leases stood at $376854.9 in 2022, then increased by 6.87% to $402755.5 in 2023, then advanced by 7.73% to $433871.1 in 2024, then plunged by 31.06% to $299092.8 in 2025, then increased by 5.97% to $316958.6 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $316958.6 in Q2 2026, $294197.8 in Q1 2026, and $299092.8 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 720.00 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 11.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 12.38 Mn |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn | 316,958.64 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 316,958.64 |
| Mar 31, 2026 | 294,197.85 |
| Dec 31, 2025 | 299,092.83 |
| Sep 30, 2025 | 316,484.26 |
| Jun 30, 2025 | 447,388.96 |
| Mar 31, 2025 | 428,310.51 |
| Dec 31, 2024 | 433,871.10 |
| Sep 30, 2024 | 438,166.52 |
| Jun 30, 2024 | 428,035.89 |
| Mar 31, 2024 | 410,741.43 |
| Dec 31, 2023 | 402,755.51 |
| Sep 30, 2023 | 385,525.41 |
| Jun 30, 2023 | 387,764.89 |
| Mar 31, 2023 | 392,260.28 |
| Dec 31, 2022 | 376,854.89 |
| Sep 30, 2022 | 377,632.01 |
| Jun 30, 2022 | 394,974.23 |
| Mar 31, 2022 | 414,901.32 |
| Dec 31, 2021 | 418,888.99 |
| Sep 30, 2021 | 429,115.53 |